Genomic Health to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum
REDWOOD CITY, Calif.,/PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the 2018 Canaccord Genuity Medical Technologies and Diagnostics Forum in New York City on Thursday, November 15, 2018 at 9:30 a.m. Eastern Time. To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company's web site at http://investor.genomichealth.com/. Please connect to the web site at least 15 minutes prior to the presentation to allow for any software download that may be necessary. An archived replay will be available for three months beginning 24 hours after the live presentation. About Genomic Health This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties are set forth in our filings with the Securities and Exchange Commission, including our most recent report on Form 10-Q for the period ended June 30, 2018. These forward-looking statements speak only as of the date hereof. Genomic Health disclaims any obligation to update these forward-looking statements. NOTE: The Genomic Health logo, Oncotype, Oncotype DX, Recurrence Score, DCIS Score, Genomic Prostate Score, Oncotype DX AR-V7 Nucleus Detect and Oncotype IQ are trademarks or registered trademarks of Genomic Health, Inc. All other trademarks and service marks are the property of their respective owners.
View original content to download multimedia:http://www.prnewswire.com/news-releases/genomic-health-to-present-at-the-2018-canaccord-genuity-medical-technologies--diagnostics-forum-300746203.html SOURCE Genomic Health, Inc. |
||
Company Codes: NASDAQ-NMS:GHDX |